When was valley fever discovered

Some of the mutilation presumably resulted from his treatment, which included not only topical methyl violet, iodine, bromine, oil of turpentine, carbolic acid, and potassium permanganate, but also excision of individual lesions and extensive curettage under chloroform anesthesia, followed by scrubbing of the raw surface with a brush soaked in bichloride solution. Nothing helped, and the patient finally died in early At autopsy, numerous nodules occupied the lungs, adrenals, lymph nodes, liver, peritoneum, prostate, spleen, and testes.

On microscopy, they were granulomas, often with caseous necrosis similar to that from miliary tuberculosis, but containing abundant protozoa-like organisms. Specimens sent to 2 microbiologists yielded no organisms for one, and the other grew a mold that he discarded as a contaminant [ 5 ].

While the patient was alive, Emmet Rixford, a surgeon at San Francisco's Cooper Medical College which became Stanford University Medical School in , studied whether the skin disease might have spread by inadvertent self-inoculation.

Apparently not, because no new lesions developed after Rixford rubbed some material containing the organism on the patient's abraded skin. Rixford experimentally created a chronic ulcer by suturing infected tissue from the patient into a rabbit's subcutaneous tissue, and the pus that formed revealed the organism.

He also inoculated some of the patient's tissue containing the microbes into a dog's leg. A lesion appeared, expanded, and ulcerated, and organisms consistently appeared in the pus exuding from the wound. Caspar Gilchrist, Rixford's coauthor on this report [ 4 ] in and a pathologist at Johns Hopkins Medical School, examined the material, confidently concluding that the microbe was not a fungus.

Instead, it was a protozoan resembling Coccidia , and helped by an eminent parasitologist, C. They inoculated tissue and pus from the case patient into the peritoneum of male guinea pigs, however, causing infection, including prominent orchitis, and they isolated the organism from the affected organs.

They injected mycelia from the cultured mold into a rabbit, which developed typical nodules containing the visible organisms in various tissues. These findings proved that C. In the life cycle of this tissue phase, the parent organism's capsule bursts, releasing the endospores, which themselves then develop into spherules. In a later experiment, he injected mold into a rabbit's ear, producing an abscess, and over the next 3 days, he observed that the organisms in the pus changed from mycelia to spherules [ 7 ].

He delineated the diversity of the anatomic areas affected, including the skin, lungs, pleura, bones, adrenal glands, genital tract, lymph nodes, and meninges. He described a few patients in whom cutaneous involvement was absent but pulmonary lesions occurred, and he suggested that some cases develop from inhalation of the organism, rather than from inoculation through the skin.

In fact, subcutaneous injection of organisms into animals did not readily produce infection [ 7 ]. During the next 2 decades [ 9 ], important articles described additional cases, emphasized the lung as the major portal of entry for the organism, presented the radiologic features of the disease, and distinguished it from infections caused by other fungi—especially blastomycosis, which Gilchrist had first reported in [ 10 ]. As with C. In , after an autopsy of a patient in the Panama Canal Zone, Samuel Darling made the same error when he detected what he felt was a protozoan, which he called Histoplasma capsulatum [ 13 ].

In fact, it too was a fungus. Thus, the 3 major endemic fungi in the United States were all initially misidentified as protozoa. In , studies on the immunology of the disease began when Cooke [ 14 ] used an extract of dried culture specimens of the organisms as an antigen for skin testing and for serologic studies of precipitin and complement fixation reactions in a case of disseminated disease.

Only the results of the precipitin test were positive. In , intradermal injection of a suspension of the fungus produced a positive skin test result in a patient with disseminated infection [ 15 ], and in , a filtrate of culture specimens obtained from another patient with disseminated disease provoked positive reactions when injected into the skin of the patient herself, but not into a human control subject [ 16 ].

Infected guinea pigs also reacted to the material, but uninfected animals did not react. In , a major insight to coccidioidomycosis inadvertently developed from the experience of a year-old, second-year medical student, Harold Chope, who was studying C. On his first day, Chope opened an old, desiccated culture to examine it more closely, and as he breathed on the plate, a cloud of spores arose, some of which he inhaled. Nine days later, he developed severe pleuritic chest pain, followed by a painful cough and purulent sputum, sometimes streaked with blood.

A chest radiograph showed right upper lobe pneumonia. His chances of surviving coccidioidal infection seemed remote, and authorities at Stanford University, no doubt distraught about their student's impending demise, provided him a private hospital room and the impressive perquisite then of a radio. Newspapers and American Weekly [ 17 ], a national magazine, featured him as a young investigator facing imminent death, soon to become a martyr to science.

One month after his exposure, he developed erythema nodosum, and sputum specimens demonstrated spherules on microscopy, yielded the organism on cultures, and caused infection when inoculated into the testes of a guinea pig—the confirmatory test then used to identify the fungus. Over the next few months, Chope gradually improved. The significance of Chope's illness became apparent when Dickson visited Kern County, California, in to solicit cooperation with the local health authorities to pursue studies of coccidioidal infections [ 21 ].

In , while reviewing case histories of C. When she mentioned this fact to Dickson, he immediately recalled Chope's case, and they hypothesized that San Joaquin fever represented C.

After Dickson's visit, the Kern County Health Department began obtaining epidemiologic histories and performing skin testing with coccidioidin for all cases of San Joaquin fever. These observations indicated that coccidioidomycosis was common in the area; racial differences, in part, determined the host's response to the fungus; and infection presumably occurred by inhaling dust containing the organism.

The domain in which C. Smith, to replace him in studying the organism [ 17 ]. During his early investigations, Smith developed pleuritic chest pain that he thought might be tuberculosis, but he was relieved when his sputum acid-fast smear results were negative. In fact, as he later recognized, he had failed to diagnose his own case of coccidioidomycosis, which he, like many others working with this organism, had acquired in the laboratory [ 17 ]. In , Smith began a month study of coccidioidomycosis in Kern and Tulare counties in the southern end of the San Joaquin Valley [ 17 , 23 ].

By contacting health departments, labor camps, and physicians in the area, he obtained the names and addresses of patients with Valley fever, defined in his study as erythema nodosum or erythema multiforme caused by C. There, poor agricultural practices and harsh drought had severely dried the topsoil, which winds blew, along with the farm crops, creating dust storms that darkened the skies, making breathing difficult and cleanliness impossible.

From his collected information, Smith made several fundamental conclusions about coccidioidal infection. By repetitive skin testing in several patients, he discovered that response to coccidioidin developed 2—17 days after symptoms began. Furthermore, cutaneous reactivity seemed long-lived. To help confirm this impression, Smith persuaded Chope, who had experienced Valley fever 9 years earlier and who had no exposure to C. It produced a large area of erythema and induration that blistered and necrosed, leaving a permanent scar.

Chope decided that his first coccidioidin skin test would also be his last [ 17 ]. Smith realized that the immunologic response to an attack, as reflected by skin reactivity to coccidioidin, seemed to protect people from further infection with C.

Moreover, among the workers in Smith's laboratory, no cases of infection occurred in those with a positive skin test result [ 23 ]. Smith also concluded that transmission of disease from one person to another did not occur, but instead, infection arose by inhalation of fungal spores. Most of the patients who he studied had shared their bed with at least one other person, and only rarely did their partners develop disease within the established incubation period. Furthermore, 18 people working in his department developed laboratory-acquired infections that could only have occurred by inhaling the organism [ 23 ].

Smith found that infection was much more common during the summer and fall, in part because the other months were wetter, but also possibly because agricultural workers did less field work during the winter and spring. Fortunately, the disease was usually self-limited, healing without clinical sequelae, but Smith noticed that persons of dark-skinned races rarely developed Valley fever. They were not exempt from C. Indeed, Gifford had earlier estimated that, compared with white persons, the risk of death from dissemination in Kern County was 23 times greater for black persons and times greater for Filipinos [ 21 ].

In Smith's study, most of the persons with Valley fever were newcomers to the region, two-thirds having arrived within the previous 2 years. She was key in the determination that San Joaquin Valley fever was caused by Coccidioides , the same fungus that caused coccidioidal granuloma.

The first Coccidioidomycosis Symposium was held in her honor and a library in the Kern County Public Health Department was named after her. Gifford lived from to Ernest C. Dickson received his MD from the University of Toronto in He was internationally known for his work on botulism.

He died in Permission: Kern County Health Department. The recognition that Chope's lengthy illness, which included pneumonia and the development of erythema nodosum with eventual spontaneous recovery, closely resembled descriptions of San Joaquin Valley fever had apparently remained fresh in Dickson's mind.

Harold Chope. His self-limited illness consisting of pneumonia and erythema nodosum after accidental laboratory exposure to Coccidioides greatly contributed to the determination that San Joaquin Valley fever was caused by the fungus.

Chope Community Hospital. The name subsequently reverted back to the original in but was subsequently changed once again, this time to the San Mateo County Medical Center. Chope lived from to Permission: Open Access. In , however, the first Coccidioidomycosis Symposium was held in her honor. All these observations were prologue to the subsequent remarkable accomplishments of Charles Smith, who received his MD from Stanford where he had been a fraternity brother of Harold Chope and his MPH from the University of Toronto, 30 before returning to Stanford where Dickson had acquired funding for him.

Smith Fig. He also went on to confirm an earlier observation by Gifford that most infections were asymptomatic as well as to establish the incubation period and demonstrate that skin test reactivity was associated with a favorable outcome. He defined endemic areas by studying coccidioidin skin test reactivity rates. Charles Smith. Smith defined the geographic and clinical epidemiology of coccidioidomycosis, among many other important contributions to our knowledge of the disease.

Born in , he died in Permission: Open Access, U. Maddy subsequently defined such areas in Arizona and identified them as largely coextensive with the Lower Sonoran Life Zone ecological niche. Smith's further investigations established the frequency of complicated including disseminated infection and its association with certain ethnic groups. He developed serological means of diagnosis with the serendipitously discovered tube precipitin test which detected anti-coccidioidal immunoglobulin M IgM antibody and the complement fixing antibody CFA test that detected immunoglobulin G IgG antibody to antigens of the fungus.

Smith also defined the time course of the rise and fall of these antibody titers and demonstrated the key clinically useful correlation between the height of the CFA titer and the extent of infection and risk of dissemination. He was also appointed Medical Director of the Coccidioidomycosis Serology Laboratory, which has remained central to the diagnosis and management of patients animal, as well as human with coccidioidomycosis throughout the country, providing personalized test interpretation and other relevant information to clinicians.

Demosthenes Pappagianis — back row, center. He worked with Smith and took over the coccidioidomycosis activities upon Smith's death in moving to the University of California at Davis, where, among other things, he became Chair of the Department of Microbiology and Medical Director of the Coccidioidomycosis Serology Group Laboratory.

In the latter capacity, he has been invaluable to clinicians by his ready availability to them, providing insightful advice regarding test interpretation and sharing his vast knowledge about coccidioidomycosis. The years since then have provided additional challenges and advances. Epidemiological events of interest included the identification of additional endemic foci quite distant from those previously defined, such as areas of northeastern Utah 35 and southeastern Washington State.

The dust clouds generated in the surrounding terrain by strong aftershocks and resultant landslides following the 6. Noteworthy were the reviews of the known geographic extent of coccidioidomycosis in Mexico by Gonzalez-Ochoa and in the Americas in general by Negroni.

Other events include the recent renewed commercial availability of a reformulated spherule-derived skin test preparation no skin test reagent had been available since 49 and of a coccidioidal antigen test.

The newly designated species was named in recognition of the physician who first reported the disease — Coccidioides posadasii. The knowledge that surviving infection due to Coccidioides generally provides life-long protection from clinically apparent illness due to subsequent exogenous infection makes coccidioidomycosis a potential target for vaccine development. Attempts to date, however, have proven unsuccessful, but possible new paths forward have been proposed and are under exploration.

When Domingo Escurra's head was discovered in , the chemotherapy of coccidioidomycosis was no more advanced, although perhaps less brutal, than it was when he had first presented for medical care more than a half-century earlier.

Escurra had unsuccessfully self-treated his lesions with topical applications of tobacco as well as incisions. The raw surfaces were then vigorously scrubbed with a bristle brush and an abundance of bichlorite solution … was applied. In , the California Department of Public Health summarized the status of the treatment of coccidioidomycosis: Amputation was the only curative intervention—but obviously only applicable to disease localized to an extremity.

In , Charles Smith was asked to provide recommendations for the treatment of John Fulton, the Sterling Professor and Chair of the Department of Physiology at Yale University who developed severe pulmonary and disseminated coccidioidomycosis possibly acquired during a visit to Smith's Stanford laboratory. Smith was, at a minimum, undoubtedly skeptical that following his own advice would produce favorable results for Fulton.

Marshall Fiese, in a presentation at the Stanford Medical Alumni Day Program, provided the following assessment: A year later, ethyl vanillate, a byproduct in the production of paper pulp, received a rousing endorsement from Dr. It has also occurred with no treatment whatsoever. Fiese went on to publish a remarkably comprehensive monograph in that proved to be a tour de force, summarizing all that was known about coccidioidomycosis at the time.

While Fiese's therapeutic nihilism was a rational assessment of the situation at the time, things were about to change for the better. In January , Streptomyces nodosum had been recovered from culture M obtained from the soil of the Orinoco River Valley in Venezuela and was subsequently found to secrete 2 molecules with antifungal activity that were given the names amphotericin A and B.

The latter proved more suitable for further development by Squibb Laboratories, 62 which had previously developed Brown and Hazen's Nystatin. Amphotericin B was quickly demonstrated to be effective in the treatment of Coccidioides infection in a murine model, 63 and its first intravenous administration to humans was reported in Fiese had initiated the administration of mg of amphotericin B by mouth every 8 hours in a patient with chronic disfiguring coccidioidal granuloma of the face on February 24, , with subsequent clinical improvement that he documented with serial photographs.

Therapeutic investigations by Hans Einstein Fig. Hans Einstein. Einstein, a distant relative of Albert his grandfather was a first cousin , spent most of his life as a physician in Bakersfield, California. He and another physician, William Winn, in Springville, California, were crucial in defining the clinical course of coccidioidomycosis and defining the use of amphotericin B in its treatment. His font of knowledge led to continual requests for consultative advice by physicians dealing with the disease.

Born on February 3, , Einstein died at age 89 on August 11, Permission: the Bakersfield Observer. William A. Winn was a personal friend of Charles Smith. He received his MD from Harvard after obtaining his undergraduate degree at Stanford. Both Einstein and Winn realized that many patients they encountered who had received a diagnosis of tuberculosis had, instead, coccidioidomycosis.

Winn delineated many of the clinical aspects of coccidioidomycosis and the appropriate use of amphotericin B, including its intrathecal administration for the treatment of coccidioidal meningitis.

He was born on September 22, , in Butte, Montana and died in Courtesy of William R. The toxicities of amphotericin B unfortunately often necessitated limitations to its use, making the development of antifungal azole drugs a welcome advance. The first of the azoles, miconazole, however, required intravenous administration and was toxic, leading to its abandonment for systemic use.

The approval of ketoconazole, an orally bioavailable azole, in was an important initial step forward, but it was subsequently supplanted by fluconazole and, later, itraconazole as well. Among other things, these drugs often proved effective in the treatment of coccidioidal meningitis, reducing the necessity intrathecal amphotericin B administration.

The newer triazoles voriconazole, posaconazole, isavuconazonium provide additional alternatives, but their precise roles remain largely undetermined. In addition, the development of lipid-associated amphotericin B products has improved the systemic tolerability of this polyene antifungal, which is believed to remain the most potent agent available in the treatment of coccidioidomycosis.

Despite these advances, it can be argued that the treatment of coccidioidomycosis remains more art than science and that, despite the work of the Mycoses Study Group and others, progress has proceeded at a glacial pace.

Among all the recommendations in the Infectious Diseases Society of America guideline for the treatment of coccidioidomycosis, none were rated as A-I good strength of evidence based on at least one randomized controlled trial. The authors report no conflicts of interest. The authors alone are responsible for the content and the writing of the paper.

The authors wish to acknowledge Dr. Shanthi Kapagoda for her insightful translation. National Center for Biotechnology Information , U. Med Mycol. Published online Jan Stan Deresinski 1 and Laurence F Mirels 2. Author information Article notes Copyright and License information Disclaimer. To whom correspondence should be addressed. Tel: For commercial re-use, please contact moc. This article has been cited by other articles in PMC. Abstract The recorded history of coccidioidomycosis began in with the report of the illness of Domingo Escurra by Alejandro Posadas followed by a description of the first North American cases by Rixford and Gilchrist.

Keywords: Coccidioidomycosis, history, amphotericin, Valley Fever. King, — Part I. Discovery, epidemiology, and clinical description In , Dr. Open in a separate window. Figure 1. Figure 2. Figure 3. Figure 4. Figure 5. Figure 6. Figure 7. Figure 8. Figure 9. Figure Part II. Treatment When Domingo Escurra's head was discovered in , the chemotherapy of coccidioidomycosis was no more advanced, although perhaps less brutal, than it was when he had first presented for medical care more than a half-century earlier.

Testing soil for Coccidioides is sometimes done as a research activity. Coccidioidomycosis acquired in Washington state external icon. Clin Infect Dis. Lockhart, Shawn R et al. March Hanna, Oltean N et al. Donor-derived organ transplant transmission of coccidioidomycosis external icon. Transpl Infect Dis. B edside interhuman transmission of coccidioidomycosis via growth on fomites. An epidemic involving six persons external icon. Am Rev Respir Dis. Coccidioidomycosis pneumonia in a nonendemic area associated with infliximab external icon.

South Med J. Fomite-transmitted coccidioidomycosis in an immunocompromised child external icon. Ped Infect Dis J. Effect of season and dust control on coccidioidomycosis. J Am Med Assoc. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, external icon.

J Infect Dis. Zender CS, Talamantes J. Climate controls on valley fever incidence in Kern County, California external icon. Int J Biometerol. Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin external icon.

Dis Chest. Werner SB, Pappagianis D. Coccidioidomycosis in Northern California. An outbreak among archeology students near Red Bluff external icon.